Citations (108)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Marwa El-Hussieny, Mansoura A. Abd-El-Maksoud, Fouad M. Soliman, Marwa A. Fouad & Mohamed K. El-Ashrey. (2023) Dual-target ligand discovery for Alzheimer’s disease: triphenylphosphoranylidene derivatives as inhibitors of acetylcholinesterase and β-amyloid aggregation. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1.
Read now
Read now
Alexandre A. de Castro, Flávia V. Soares, Ander F. Pereira, Daniel A. Polisel, Melissa S. Caetano, Daniel H. S. Leal, Elaine F. F. da Cunha, Eugenie Nepovimova, Kamil Kuca & Teodorico C. Ramalho. (2019) Non-conventional compounds with potential therapeutic effects against Alzheimer’s disease. Expert Review of Neurotherapeutics 19:5, pages 375-395.
Read now
Read now
Ayesha Khan, Anne Corbett & Clive Ballard. (2017) Emerging amyloid and tau targeting treatments for Alzheimer’s disease. Expert Review of Neurotherapeutics 17:7, pages 697-711.
Read now
Read now
Ayesha Khan, Anne Corbett & Clive Ballard. (2017) Emerging treatments for Alzheimer’s disease for non-amyloid and non-tau targets. Expert Review of Neurotherapeutics 17:7, pages 683-695.
Read now
Read now
Harald Hampel, Lon S Schneider, Ezio Giacobini, Miia Kivipelto, Shireen Sindi, Bruno Dubois, Karl Broich, Robert Nisticò, Paul S Aisen & Simone Lista. (2015) Advances in the therapy of Alzheimer’s disease: targeting amyloid beta and tau and perspectives for the future. Expert Review of Neurotherapeutics 15:1, pages 83-105.
Read now
Read now
Pamela E Potter. (2013) Curcumin: a natural substance with potential efficacy in Alzheimer’s disease. Journal of Experimental Pharmacology 5, pages 23-31.
Read now
Read now
Laura Ghezzi, Elio Scarpini & Daniela Galimberti. (2013) Disease-modifying drugs in Alzheimer’s disease. Drug Design, Development and Therapy 7, pages 1471-1479.
Read now
Read now
Anne Corbett & Clive Ballard. (2012) New and emerging treatments for Alzheimer's disease. Expert Opinion on Emerging Drugs 17:2, pages 147-156.
Read now
Read now
Anne Corbett, Jessica Smith & Clive Ballard. (2012) New and emerging treatments for Alzheimer’s disease. Expert Review of Neurotherapeutics 12:5, pages 535-543.
Read now
Read now
Grazia D'Onofrio, Francesco Panza, Vincenza Frisardi, Vincenzo Solfrizzi, Bruno P Imbimbo, Giulia Paroni, Leandro Cascavilla, Davide Seripa & Alberto Pilotto. (2012) Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease. Expert Opinion on Drug Discovery 7:1, pages 19-37.
Read now
Read now
Articles from other publishers (98)
Anjali Sharma, Rayala Swetha, Nilesh Gajanan Bajad, Ankit Ganeshpurkar, Ravi Singh, Ashok Kumar & Sushil Kumar Singh. (2022) Cathepsin B-A Neuronal Death Mediator in Alzheimer’s Disease Leading to Neurodegeneration. Mini-Reviews in Medicinal Chemistry 22:15, pages 2012-2023.
Crossref
Crossref
Yifan Lu, Peiqi Wang, Li He, Shouwen Jin, Bin Liu, Bin Chen & Daqi Wang. (2022) Preparation and characterization of five 3D crystalline adducts from caffeine and organic acids. Journal of Molecular Structure 1260, pages 132697.
Crossref
Crossref
Huda S. Darusman, Uus Saepuloh, Sela S. Mariya, Dondin Sajuthi, Steven J. Schapiro & Jann Hau. (2021) Increased expression of GAPDH in cynomolgus monkeys with spontaneous cognitive decline and amyloidopathy reminiscent of an Alzheimer's‐type disease is reflected in the circulation. American Journal of Primatology 83:11.
Crossref
Crossref
Željko M. Svedružić, Katarina Vrbnjak, Manuel Martinović & Vedran Miletić. (2021) Structural Analysis of the Simultaneous Activation and Inhibition of γ-Secretase Activity in the Development of Drugs for Alzheimer’s Disease. Pharmaceutics 13:4, pages 514.
Crossref
Crossref
Ankit Tandon, Sangh J. Singh & Rajnish K. Chaturvedi. (2021) Nanomedicine against Alzheimer’s and Parkinson’s Disease. Current Pharmaceutical Design 27:12, pages 1507-1545.
Crossref
Crossref
A G Eliewi, Z S Al-Garawi, F F Al-Kazzaz & A J K Atia. (2021) Multi target-directed imidazole derivatives for neurodegenerative diseases. Journal of Physics: Conference Series 1853:1, pages 012066.
Crossref
Crossref
Ashutosh Paliwal, Ashwini Kumar Nigam, Jalaj Kumar Gour, Deepak Singh, Pooja Pandey & Manoj Kumar Singh. 2021. Naturally Occurring Chemicals Against Alzheimer's Disease. Naturally Occurring Chemicals Against Alzheimer's Disease
49
63
.
Vipul Chaudhary, Ashwini Kumar Nigam, Ashutosh Paliwal, Manoj Kumar Singh, Jalaj Kumar Gour & Vimlendu Bhushan Sinha. 2021. Naturally Occurring Chemicals Against Alzheimer's Disease. Naturally Occurring Chemicals Against Alzheimer's Disease
65
82
.
Kevin D. Rynearson, Ronald N. Buckle, R. Jason Herr, Nicholas J. Mayhew, Xinchao Chen, William D. Paquette, Samuel A. Sakwa, Jinhai Yang, Keith D. Barnes, Phuong Nguyen, William C. Mobley, Graham Johnson, Juinn H. Lin, Rudolph E. Tanzi & Steven L. Wagner. (2020) Design and synthesis of novel methoxypyridine-derived gamma-secretase modulators. Bioorganic & Medicinal Chemistry 28:22, pages 115734.
Crossref
Crossref
Weiming Xia. (2019) γ-Secretase and its modulators: Twenty years and beyond. Neuroscience Letters 701, pages 162-169.
Crossref
Crossref
Sales, Prandi, Castro, Leal, Cunha, Kuca & Ramalho. (2019) Recent Developments in Metal-Based Drugs and Chelating Agents for Neurodegenerative Diseases Treatments. International Journal of Molecular Sciences 20:8, pages 1829.
Crossref
Crossref
Suraj S. Patil, Dipak D. Kumbhar, Jagdish V. Manwar, Rajesh G. Jadhao, Ravindra L. Bakal & Sharad Wakode. (2019) Ultrasound-Assisted Facile Synthesis of Nanostructured Hybrid Vesicle for the Nasal Delivery of Indomethacin: Response Surface Optimization, Microstructure, and Stability. AAPS PharmSciTech 20:3.
Crossref
Crossref
Maria Z. Kounnas, Murat S. Durakoglugil, Joachim Herz & William T. Comer. (2019) NGP 555, a γ‐secretase modulator, shows a beneficial shift in the ratio of amyloid biomarkers in human cerebrospinal fluid at safe doses. Alzheimer's & Dementia: Translational Research & Clinical Interventions 5:1, pages 458-467.
Crossref
Crossref
Florent Alix, Vincent Gembus, Laurent Coquet, Marie Hubert-Roux, Philippe Chan, Lina Truong, Muriel Sebban, Gaël Coadou, Hassan Oulyadi, Cyril Papamicaël & Vincent Levacher. (2018) Dihydroquinoline Carbamate DQS1-02 as a Prodrug of a Potent Acetylcholinesterase Inhibitor for Alzheimer’s Disease Therapy: Multigram-Scale Synthesis, Mechanism Investigations, in Vitro Safety Pharmacology, and Preliminary in Vivo Toxicology Profile. ACS Omega 3:12, pages 18387-18397.
Crossref
Crossref
Martina Audagnotto, Alexander Kengo Lorkowski & Matteo Dal Peraro. (2018) Recruitment of the amyloid precursor protein by γ-secretase at the synaptic plasma membrane. Biochemical and Biophysical Research Communications 498:2, pages 334-341.
Crossref
Crossref
Dongtak Lee, Gyudo Lee & Dae Sung Yoon. (2018) Anti-Aβ drug candidates in clinical trials and plasmonic nanoparticle-based drug-screen for Alzheimer's disease. The Analyst 143:10, pages 2204-2212.
Crossref
Crossref
Menizibeya Osain WelcomeMenizibeya Osain Welcome. 2018. Gastrointestinal Physiology. Gastrointestinal Physiology
871
972
.
Md. Rashidur Rahman, Afsana Tajmim, Mohammad Ali & Mostakim Sharif. (2017) Overview and Current Status of Alzheimer’s Disease in Bangladesh. Journal of Alzheimer's Disease Reports 1:1, pages 27-42.
Crossref
Crossref
Hong-Yi Zhao, Hui-Juan Wu, Jia-Lin He, Jian-Hua Zhuang, Zhen-Yu Liu, Liu-Qing Huang & Zhong-Xin Zhao. (2017) Chronic Sleep Restriction Induces Cognitive Deficits and Cortical Beta-Amyloid Deposition in Mice via BACE1-Antisense Activation. CNS Neuroscience & Therapeutics 23:3, pages 233-240.
Crossref
Crossref
Maria Z. Kounnas, Courtney Lane-Donovan, Dan W. Nowakowski, Joachim Herz & William T. Comer. (2017)
NGP 555, a γ-secretase modulator, lowers the amyloid biomarker, Aβ
42,
in cerebrospinal fluid while preventing Alzheimer's disease cognitive decline in rodents
. Alzheimer's & Dementia: Translational Research & Clinical Interventions 3:1, pages 65-73.
Crossref
Crossref
Dnyanesh S. Ranade, Archika M. Bapat, Shefali N. Ramteke, Bimba N. Joshi, Pascal Roussel, Alain Tomas, Patrick Deschamps & Prasad P. Kulkarni. (2016) Thiosemicarbazone modification of 3-acetyl coumarin inhibits Aβ peptide aggregation and protect against Aβ-induced cytotoxicity. European Journal of Medicinal Chemistry 121, pages 803-809.
Crossref
Crossref
Kevin D. Rynearson, Ronald N. Buckle, Keith D. Barnes, R. Jason Herr, Nicholas J. Mayhew, William D. Paquette, Samuel A. Sakwa, Phuong D. Nguyen, Graham Johnson, Rudolph E. Tanzi & Steven L. Wagner. (2016) Design and synthesis of aminothiazole modulators of the gamma-secretase enzyme. Bioorganic & Medicinal Chemistry Letters 26:16, pages 3928-3937.
Crossref
Crossref
Robert H. Scannevin, Sowmya Chollate, Melanie S. Brennan, Pamela A. Snodgrass-Belt, Hairuo Peng, Lin Xu, Mi-young Jung, Thierry Bussiere, Mahin F. Arastu, Tina Talreja, Zhili Xin, Robert W. Dunstan, Diana Fahrer, Ellen Rohde, Anthone W. Dunah, Joy Wang, Gnanasambandam Kumaravel, Arthur G. Taveras, H. Moore Arnold & Kenneth J. Rhodes. (2016) BIIB042, a novel γ-secretase modulator, reduces amyloidogenic Aβ isoforms in primates and rodents and plaque pathology in a mouse model of Alzheimer's disease. Neuropharmacology 103, pages 57-68.
Crossref
Crossref
Youhei Sohma. (2016) Medicinal Chemistry Focusing on Aggregation of Amyloid-β. CHEMICAL & PHARMACEUTICAL BULLETIN Chemical and Pharmaceutical Bulletin 64:1, pages 1-7.
Crossref
Crossref
Kevin D. Rynearson, Rudolph E. Tanzi & Steven L. Wagner. 2016. Translational Neuroscience. Translational Neuroscience
359
368
.
Andr?s Ricardo L?pez, Mitko Dimitrov, Hermeto Gerber, Virginie Braman, David L. Hacker, Florian M. Wurm & Patrick C. Fraering. (2015) Production of active glycosylation-deficient ?-secretase complex for crystallization studies. Biotechnology and Bioengineering 112:12, pages 2516-2526.
Crossref
Crossref
Ruth MacLeod, Ellin-Kristina Hillert, Ryan T Cameron & George S Baillie. (2015) The role and therapeutic targeting of α-, β- and γ-secretase in Alzheimer's disease. Future Science OA 1:3.
Crossref
Crossref
Jaspreet Kalra & Aamir Khan. (2015) Reducing Aβ load and tau phosphorylation: Emerging perspective for treating Alzheimer's disease. European Journal of Pharmacology 764, pages 571-581.
Crossref
Crossref
Christian Fischer, Susan L. Zultanski, Hua Zhou, Joey L. Methot, Sanjiv Shah, Ikuo Hayashi, Bethany L. Hughes, Christopher M. Moxham, Nathan W. Bays, Nadya Smotrov, Armetta D. Hill, Bo-Sheng Pan, Zhenhua Wu, Lily Y. Moy, Flobert Tanga, Candia Kenific, Jonathan C. Cruz, Deborah Walker, Melanie Bouthillette, George N. Nikov, Sujal V. Deshmukh, Valentina V. Jeliazkova-Mecheva, Damaris Diaz, Maria S. Michener, Jacquelynn J. Cook, Benito Munoz & Mark S. Shearman. (2015) Discovery of novel triazolobenzazepinones as γ-secretase modulators with central Aβ42 lowering in rodents and rhesus monkeys. Bioorganic & Medicinal Chemistry Letters 25:17, pages 3488-3494.
Crossref
Crossref
Joey L. Methot, Christian Fischer, Chaomin Li, Alexey Rivkin, Sean P. Ahearn, William Colby Brown, Sam Kattar, Elizabeth Kelley, Dawn M. Mampreian, Adam Schell, Andrew Rosenau, Hua Zhou, Richard Ball, Sujal V. Deshmukh, Valentina V. Jeliazkova-Mecheva, Damaris Diaz, Lily Y. Moy, Candia M. Kenific, Chris Moxham, Sanjiv Shah, Hugh Nuthall, Alexander A. Szewczak, Armetta Hill, Bethany Hughes, Nadya Smotrov, Benito Munoz, Thomas A. Miller & Mark S. Shearman. (2015) Potent benzoazepinone γ-secretase modulators with improved bioavailability. Bioorganic & Medicinal Chemistry Letters 25:17, pages 3495-3500.
Crossref
Crossref
Jitendra Kumar, Risa Namsechi & Valerie L. Sim. (2015) Structure-Based Peptide Design to Modulate Amyloid Beta Aggregation and Reduce Cytotoxicity. PLOS ONE 10:6, pages e0129087.
Crossref
Crossref
Sahar Elsayed El-Swefy & Hebatallah Husseini Atteia. 2015. The Mediterranean Diet. The Mediterranean Diet
441
448
.
Yu Ohki, Naoaki Shimada, Aya Tominaga, Satoko Osawa, Takuya Higo, Satoshi Yokoshima, Tohru Fukuyama, Taisuke Tomita & Takeshi Iwatsubo. (2014) Binding of longer Aβ to transmembrane domain 1 of presenilin 1 impacts on Aβ42 generation. Molecular Neurodegeneration 9:1.
Crossref
Crossref
Tadamasa Arai, Takushi Araya, Daisuke Sasaki, Atsuhiko Taniguchi, Takeshi Sato, Youhei Sohma & Motomu Kanai. (2014)
Rational Design and Identification of a Non-Peptidic Aggregation Inhibitor of Amyloid-? Based on a Pharmacophore Motif Obtained from
cyclo
[-Lys-Leu-Val-Phe-Phe-]
. Angewandte Chemie International Edition 53:31, pages 8236-8239.
Crossref
Crossref
Tadamasa Arai, Takushi Araya, Daisuke Sasaki, Atsuhiko Taniguchi, Takeshi Sato, Youhei Sohma & Motomu Kanai. (2014)
Rational Design and Identification of a Non‐Peptidic Aggregation Inhibitor of Amyloid‐β Based on a Pharmacophore Motif Obtained from
cyclo
[‐Lys‐Leu‐Val‐Phe‐Phe‐]
. Angewandte Chemie 126:31, pages 8375-8378.
Crossref
Crossref
Kunihiko Kanatsu, Yuichi Morohashi, Mai Suzuki, Hiromasa Kuroda, Toshio Watanabe, Taisuke Tomita & Takeshi Iwatsubo. (2014) Decreased CALM expression reduces Aβ42 to total Aβ ratio through clathrin-mediated endocytosis of γ-secretase. Nature Communications 5:1.
Crossref
Crossref
Steven L. Wagner, Can Zhang, Soan Cheng, Phuong Nguyen, Xulun Zhang, Kevin D. Rynearson, Rong Wang, Yueming Li, Sangram S. Sisodia, William C. Mobley & Rudolph E. Tanzi. (2014) Soluble γ-Secretase Modulators Selectively Inhibit the Production of the 42-Amino Acid Amyloid β Peptide Variant and Augment the Production of Multiple Carboxy-Truncated Amyloid β Species. Biochemistry 53:4, pages 702-713.
Crossref
Crossref
Jing Xu, Michelle H. Lacoske & Emmanuel A. Theodorakis. (2014) Neurotrophic Natural Products: Chemistry and Biology. Angewandte Chemie International Edition 53:4, pages 956-987.
Crossref
Crossref
Jing Xu, Michelle H. Lacoske & Emmanuel A. Theodorakis. (2013) Neurotrophe Naturstoffe – ihre Chemie und Biologie. Angewandte Chemie 126:4, pages 972-1004.
Crossref
Crossref
Qiutian Jia, Yulin Deng & Hong Qing. (2014)
Potential Therapeutic Strategies for Alzheimer’s Disease Targeting or Beyond
β
-Amyloid: Insights from Clinical Trials
. BioMed Research International 2014, pages 1-22.
Crossref
Crossref
G.S. Suresh Kumar, P.G. Seethalakshmi, N. Bhuvanesh & S. Kumaresan. (2013) Studies on the syntheses, structural characterization, antimicrobial-, and DPPH radical scavenging activity of the cocrystals caffeine:cinnamic acid and caffeine:eosin dihydrate. Journal of Molecular Structure 1050, pages 88-96.
Crossref
Crossref
Subhash Ajmani, Sridhara Janardhan & Vellarkad N. Viswanadhan. (2013) Toward a general predictive QSAR model for gamma-secretase inhibitors. Molecular Diversity 17:3, pages 421-434.
Crossref
Crossref
Nobumasa Takasugi, Tomoki Sasaki, Ihori Ebinuma, Satoko Osawa, Hayato Isshiki, Koji Takeo, Taisuke Tomita & Takeshi Iwatsubo. (2013) FTY720/Fingolimod, a Sphingosine Analogue, Reduces Amyloid-β Production in Neurons. PLoS ONE 8:5, pages e64050.
Crossref
Crossref
Taisuke Tomita & Takeshi Iwatsubo. (2013) Structural Biology of Presenilins and Signal Peptide Peptidases. Journal of Biological Chemistry 288:21, pages 14673-14680.
Crossref
Crossref
Benedikt Kretner, Akio Fukumori, Peer‐Hendrik Kuhn, Blanca Isabel Pérez‐Revuelta, Stefan F. Lichtenthaler, Christian Haass & Harald Steiner. (2013)
Important functional role of residue x of the presenilin Gx
GD
protease active site motif for
APP
substrate cleavage specificity and substrate selectivity of γ‐secretase
. Journal of Neurochemistry 125:1, pages 144-156.
Crossref
Crossref
Yuki Imamura, Naoki Umezawa, Satoko Osawa, Naoaki Shimada, Takuya Higo, Satoshi Yokoshima, Tohru Fukuyama, Takeshi Iwatsubo, Nobuki Kato, Taisuke Tomita & Tsunehiko Higuchi. (2013) Effect of Helical Conformation and Side Chain Structure on γ-Secretase Inhibition by β-Peptide Foldamers: Insight into Substrate Recognition. Journal of Medicinal Chemistry 56:4, pages 1443-1454.
Crossref
Crossref
G.S. Suresh Kumar, P.G. Seethalakshmi, N. Bhuvanesh & S. Kumaresan. (2013) Cocrystals of caffeine with formylphenoxyaliphatic acids: Syntheses, structural characterization, and biological activity. Journal of Molecular Structure 1034, pages 302-309.
Crossref
Crossref
Shizuka Takagi-Niidome, Satoko Osawa, Taisuke Tomita & Takeshi Iwatsubo. (2012) Inhibition of γ-Secretase Activity by a Monoclonal Antibody against the Extracellular Hydrophilic Loop of Presenilin 1. Biochemistry 52:1, pages 61-69.
Crossref
Crossref
Željko M. Svedružić, Katarina Popović & Vesna Šendula-Jengić. (2013) Modulators of γ-Secretase Activity Can Facilitate the Toxic Side-Effects and Pathogenesis of Alzheimer's Disease. PLoS ONE 8:1, pages e50759.
Crossref
Crossref
Xiao-Fen Chen, Yun-wu Zhang, Huaxi Xu & Guojun Bu. (2013) Transcriptional regulation and its misregulation in Alzheimer’s disease. Molecular Brain 6:1, pages 44.
Crossref
Crossref
Francois Bischoff, Didier Berthelot, Michel De Cleyn, Gregor Macdonald, Garrett Minne, Daniel Oehlrich, Serge Pieters, Michel Surkyn, Andrés A. Trabanco, Gary Tresadern, Sven Van Brandt, Ingrid Velter, Mirko Zaja, Herman Borghys, Chantal Masungi, Marc Mercken & Harrie J. M. Gijsen. (2012) Design and Synthesis of a Novel Series of Bicyclic Heterocycles As Potent γ-Secretase Modulators. Journal of Medicinal Chemistry 55:21, pages 9089-9106.
Crossref
Crossref
Anna Nogalska, Carla D'Agostino, W. King Engel & Valerie Askanas. (2012) Activation of the ?-secretase complex and presence of ?-secretase-activating protein may contribute to A?42 production in sporadic inclusion-body myositis muscle fibers. Neurobiology of Disease 48:1, pages 141-149.
Crossref
Crossref
Heiko Zettl, Julia Ness, Volker Hähnke, Dirk Beher, Thorsten Jumpertz, Arman Saric, Karlheinz Baumann, Claus U. Pietrzik, Bruno Bulic, Gisbert Schneider & Sascha Weggen. (2012) Discovery of γ-Secretase Modulators with a Novel Activity Profile by Text-Based Virtual Screening. ACS Chemical Biology 7:9, pages 1488-1495.
Crossref
Crossref
Vishal Gulati & Ron Wallace. (2012) Rafts, Nanoparticles and Neural Disease. Nanomaterials 2:3, pages 217-250.
Crossref
Crossref
Koji Takeo, Naoto Watanabe, Taisuke Tomita & Takeshi Iwatsubo. (2012) Contribution of the γ-Secretase Subunits to the Formation of Catalytic Pore of Presenilin 1 Protein. Journal of Biological Chemistry 287:31, pages 25834-25843.
Crossref
Crossref
Leon M. Tai, Helmut Jacobsen, Laurence Ozmen, Alexander Flohr, Roland Jakob-Roetne, Antonello Caruso & Hans-Peter Grimm. (2012) The dynamics of Aβ distribution after γ-secretase inhibitor treatment, as determined by experimental and modelling approaches in a wild type rat. Journal of Pharmacokinetics and Pharmacodynamics 39:3, pages 227-237.
Crossref
Crossref
Christian Fischer, Susan L. Zultanski, Hua Zhou, Joey L. Methot, Sanjiv Shah, Hugh Nuthall, Bethany L. Hughes, Nadja Smotrov, Armetta Hill, Alexander A. Szewczak, Christopher M. Moxham, Nathan Bays, Richard E. Middleton, Benito Munoz & Mark S. Shearman. (2012) Triazoloamides as potent γ-secretase modulators with reduced hERG liability. Bioorganic & Medicinal Chemistry Letters 22:9, pages 3140-3146.
Crossref
Crossref
Kangning Liu, Minhua Zhang & Guhan Nagappan. 2012. Alzheimer's Disease. Alzheimer's Disease
163
210
.
Salvatore Salomone, Filippo Caraci, Gian Marco Leggio, Julia Fedotova & Filippo Drago. (2012) New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs. British Journal of Clinical Pharmacology 73:4, pages 504-517.
Crossref
Crossref
Johannes Prox, Andrea Rittger & Paul Saftig. (2011) Physiological functions of the amyloid precursor protein secretases ADAM10, BACE1, and Presenilin. Experimental Brain Research 217:3-4, pages 331-341.
Crossref
Crossref
Željko M. Svedružić, Katarina Popović, Ivana Smoljan & Vesna Šendula-Jengić. (2012) Modulation of γ-Secretase Activity by Multiple Enzyme-Substrate Interactions: Implications in Pathogenesis of Alzheimer's Disease. PLoS ONE 7:3, pages e32293.
Crossref
Crossref
I Hayashi, S Takatori, Y Urano, Y Miyake, J Takagi, M Sakata-Yanagimoto, H Iwanari, S Osawa, Y Morohashi, T Li, P C Wong, S Chiba, T Kodama, T Hamakubo, T Tomita & T Iwatsubo. (2011) Neutralization of the γ-secretase activity by monoclonal antibody against extracellular domain of nicastrin. Oncogene 31:6, pages 787-798.
Crossref
Crossref
Thorsten Jumpertz, Andreas Rennhack, Julia Ness, Sandra Baches, Claus U. Pietrzik, Bruno Bulic & Sascha Weggen. (2012) Presenilin Is the Molecular Target of Acidic γ-Secretase Modulators in Living Cells. PLoS ONE 7:1, pages e30484.
Crossref
Crossref
Christiane Reitz. (2012) Alzheimer's Disease and the Amyloid Cascade Hypothesis: A Critical Review. International Journal of Alzheimer's Disease 2012, pages 1-11.
Crossref
Crossref
Masaya Koshizaka, Minoru Takemoto, Seiya Sato, Hirotake Tokuyama, Masaki Fujimoto, Emiko Okabe, Ryoichi Ishibashi, Takahiro Ishikawa, Yuya Tsurutani, Shunichiro Onishi, Morito Mezawa, Peng He, Satoshi Honjo, Shiro Ueda, Yasushi Saito & Koutaro Yokote. (2012) An Angiotensin II Type 1 Receptor Blocker Prevents Renal Injury via Inhibition of the Notch Pathway in Ins2 Akita Diabetic Mice. Experimental Diabetes Research 2012, pages 1-10.
Crossref
Crossref
Aarti N. Patel & Jack H. Jhamandas. (2012) Neuronal receptors as targets for the action of amyloid-beta protein (Aβ) in the brain. Expert Reviews in Molecular Medicine 14.
Crossref
Crossref
Yu Ohki, Takuya Higo, Kengo Uemura, Naoaki Shimada, Satoko Osawa, Oksana Berezovska, Satoshi Yokoshima, Tohru Fukuyama, Taisuke Tomita & Takeshi Iwatsubo. (2011) Phenylpiperidine-type γ-secretase modulators target the transmembrane domain 1 of presenilin 1. The EMBO Journal 30:23, pages 4815-4824.
Crossref
Crossref
Fadi Massoud & Gabriel C Léger. (2011) Pharmacological Treatment of Alzheimer Disease. The Canadian Journal of Psychiatry 56:10, pages 579-588.
Crossref
Crossref
Masashi Asai, Sosuke Yagishita, Nobuhisa Iwata, Takaomi C. Saido, Shoichi Ishiura & Kei Maruyama. (2011)
An alternative metabolic pathway of amyloid precursor protein C‐terminal fragments
via
cathepsin B in a human neuroglioma model
. The FASEB Journal 25:10, pages 3720-3730.
Crossref
Crossref
Amelie Ebke, Thomas Luebbers, Akio Fukumori, Keiro Shirotani, Christian Haass, Karlheinz Baumann & Harald Steiner. (2011) Novel γ-Secretase Enzyme Modulators Directly Target Presenilin Protein. Journal of Biological Chemistry 286:43, pages 37181-37186.
Crossref
Crossref
Francesco Panza, Vincenza Frisardi, Bruno P Imbimbo, Davide Seripa, Vincenzo Solfrizzi & Alberto Pilotto. (2011) ?-secretase inhibitors for treating Alzheimer?s disease: rationale and clinical data. Clinical Investigation 1:8, pages 1175-1194.
Crossref
Crossref
Christian Fischer, Susan L. Zultanski, Hua Zhou, Joey L. Methot, W. Colby Brown, Dawn M. Mampreian, Adam J. Schell, Sanjiv Shah, Hugh Nuthall, Bethany L. Hughes, Nadja Smotrov, Candia M. Kenific, Jonathan C. Cruz, Deborah Walker, Melanie Bouthillette, George N. Nikov, Dan F. Savage, Valentina V. Jeliazkova-Mecheva, Damaris Diaz, Alexander A. Szewczak, Nathan Bays, Richard E. Middleton, Benito Munoz & Mark S. Shearman. (2011) Triazoles as ?-secretase modulators. Bioorganic & Medicinal Chemistry Letters 21:13, pages 4083-4087.
Crossref
Crossref
Stefan F. Lichtenthaler, Christian Haass & Harald Steiner. (2011) Regulated intramembrane proteolysis - lessons from amyloid precursor protein processing. Journal of Neurochemistry 117:5, pages 779-796.
Crossref
Crossref
Nobumasa Takasugi, Tomoki Sasaki, Kunimichi Suzuki, Satoko Osawa, Hayato Isshiki, Yukiko Hori, Naoaki Shimada, Takuya Higo, Satoshi Yokoshima, Tohru Fukuyama, Virginia M.-Y. Lee, John Q. Trojanowski, Taisuke Tomita & Takeshi Iwatsubo. (2011) BACE1 Activity Is Modulated by Cell-Associated Sphingosine-1-Phosphate. The Journal of Neuroscience 31:18, pages 6850-6857.
Crossref
Crossref
Benedikt Kretner, Akio Fukumori, Amelie Gutsmiedl, Richard M. Page, Thomas Luebbers, Guido Galley, Karlheinz Baumann, Christian Haass & Harald Steiner. (2011) Attenuated Aβ42 Responses to Low Potency γ-Secretase Modulators Can Be Overcome for Many Pathogenic Presenilin Mutants by Second-generation Compounds. Journal of Biological Chemistry 286:17, pages 15240-15251.
Crossref
Crossref
Daniel Oehlrich, Didier J.-C. Berthelot & Harrie J. M. Gijsen. (2010) γ-Secretase Modulators as Potential Disease Modifying Anti-Alzheimer’s Drugs. Journal of Medicinal Chemistry 54:3, pages 669-698.
Crossref
Crossref
Christian Fischer, Sanjiv Shah, Bethany L. Hughes, George N. Nikov, Jamie L. Crispino, Richard E. Middleton, Alexander A. Szewczak, Benito Munoz & Mark S. Shearman. (2011) Quinazolinones as ?-secretase modulators. Bioorganic & Medicinal Chemistry Letters 21:2, pages 773-776.
Crossref
Crossref
Shizuka Takagi, Aya Tominaga, Chihiro Sato, Taisuke Tomita & Takeshi Iwatsubo. (2010) Participation of Transmembrane Domain 1 of Presenilin 1 in the Catalytic Pore Structure of the γ-Secretase. The Journal of Neuroscience 30:47, pages 15943-15950.
Crossref
Crossref
Anh P. Truong, Gergley Tóth, Gary D. Probst, Jennifer M. Sealy, Simeon Bowers, David W.G. Wone, Darren Dressen, Roy K. Hom, Andrei W. Konradi, Hing L. Sham, Jing Wu, Brian T. Peterson, Lany Ruslim, Michael P. Bova, Dora Kholodenko, Ruth N. Motter, Frédérique Bard, Pamela Santiago, Huifang Ni, David Chian, Ferdie Soriano, Tracy Cole, Elizabeth F. Brigham, Karina Wong, Wes Zmolek, Erich Goldbach, Bhushan Samant, Linda Chen, Hongbing Zhang, David F. Nakamura, Kevin P. Quinn, Ted A. Yednock & John-Michael Sauer. (2010) Design of an orally efficacious hydroxyethylamine (HEA) BACE-1 inhibitor in a preclinical animal model. Bioorganic & Medicinal Chemistry Letters 20:21, pages 6231-6236.
Crossref
Crossref
Heiko Zettl, Sascha Weggen, Petra Schneider & Gisbert Schneider. (2010) Exploring the chemical space of γ-secretase modulators. Trends in Pharmacological Sciences 31:9, pages 402-410.
Crossref
Crossref
Maria Z. Kounnas, Anne M. Danks, Soan Cheng, Curtis Tyree, Elizabeth Ackerman, Xulun Zhang, Kwangwook Ahn, Phuong Nguyen, Dan Comer, Long Mao, Chengzhi Yu, David Pleynet, Paul J. Digregorio, Gonul Velicelebi, Kenneth A. Stauderman, William T. Comer, William C. Mobley, Yue-Ming Li, Sangram S. Sisodia, Rudolph E. Tanzi & Steven L. Wagner. (2010) Modulation of γ-Secretase Reduces β-Amyloid Deposition in a Transgenic Mouse Model of Alzheimer's Disease. Neuron 67:5, pages 769-780.
Crossref
Crossref
Motonori Kurosumi, Yoshino Nishio, Satoko Osawa, Hisayoshi Kobayashi, Takeshi Iwatsubo, Taisuke Tomita & Hiroyuki Miyachi. (2010) Novel Notch-sparing γ-secretase inhibitors derived from a peroxisome proliferator-activated receptor agonist library. Bioorganic & Medicinal Chemistry Letters 20:17, pages 5282-5285.
Crossref
Crossref
Anh P. Truong, Gary D. Probst, Jose Aquino, Larry Fang, Louis Brogley, Jennifer M. Sealy, Roy K. Hom, John A. Tucker, Varghese John, Jay S. Tung, Michael A. Pleiss, Andrei W. Konradi, Hing L. Sham, Michael S. Dappen, Gergley Tóth, Nanhua Yao, Eric Brecht, Hu Pan, Dean R. Artis, Lany Ruslim, Michael P. Bova, Sukanto Sinha, Ted A. Yednock, Wes Zmolek, Kevin P. Quinn & John-Michael Sauer. (2010) Improving the permeability of the hydroxyethylamine BACE-1 inhibitors: Structure–activity relationship of P2′ substituents. Bioorganic & Medicinal Chemistry Letters 20:16, pages 4789-4794.
Crossref
Crossref
Francesca Mangialasche, Alina Solomon, Bengt Winblad, Patrizia Mecocci & Miia Kivipelto. (2010) Alzheimer's disease: clinical trials and drug development. The Lancet Neurology 9:7, pages 702-716.
Crossref
Crossref
Richard M. Page, Amelie Gutsmiedl, Akio Fukumori, Edith Winkler, Christian Haass & Harald Steiner. (2010) β-Amyloid Precursor Protein Mutants Respond to γ-Secretase Modulators. Journal of Biological Chemistry 285:23, pages 17798-17810.
Crossref
Crossref
Naoto Watanabe 渡邊 直登, Shizuka Takagi 高木 穏香, Aya Tominaga 富永 綾, Taisuke Tomita 富田 泰輔 & Takeshi Iwatsubo 岩坪 威. (2010) Functional Analysis of the Transmembrane Domains of Presenilin 1. Journal of Biological Chemistry 285:26, pages 19738-19746.
Crossref
Crossref
Jacquelynn J. Cook, Kristin R. Wildsmith, David B. Gilberto, Marie A. Holahan, Gene G. Kinney, Parker D. Mathers, Maria S. Michener, Eric A. Price, Mark S. Shearman, Adam J. Simon, Jennifer X. Wang, Guoxin Wu, Kevin E. Yarasheski & Randall J. Bateman. (2010) Acute γ-Secretase Inhibition of Nonhuman Primate CNS Shifts Amyloid Precursor Protein (APP) Metabolism from Amyloid-β Production to Alternative APP Fragments without Amyloid-β Rebound. The Journal of Neuroscience 30:19, pages 6743-6750.
Crossref
Crossref
Drew S. Folk & Katherine J. Franz. (2010) A Prochelator Activated by β-Secretase Inhibits Aβ Aggregation and Suppresses Copper-Induced Reactive Oxygen Species Formation. Journal of the American Chemical Society 132:14, pages 4994-4995.
Crossref
Crossref
Jean‐Marc Taymans & Mark R. Cookson. (2010) Mechanisms in dominant parkinsonism: The toxic triangle of LRRK2, α‐synuclein, and tau. BioEssays 32:3, pages 227-235.
Crossref
Crossref
Guojun Zhao, Zhenyi Liu, Ma. Xenia G. Ilagan & Raphael Kopan. (2010) γ-Secretase Composed of PS1/Pen2/Aph1a Can Cleave Notch and Amyloid Precursor Protein in the Absence of Nicastrin. The Journal of Neuroscience 30:5, pages 1648-1656.
Crossref
Crossref
Jing Nie, Yong Luo, Xie-Nan Huang, Qi-Hai Gong, Qin Wu & Jing-Shan Shi. (2010) Icariin inhibits beta-amyloid peptide segment 25–35 induced expression of β-secretase in rat hippocampus. European Journal of Pharmacology 626:2-3, pages 213-218.
Crossref
Crossref
Hans-Gert Bernstein, Theresia S. Ernst, Uwe Lendeckel, Henrik Dobrowolny, Johann Steiner & Bernhard Bogerts. 2010. Brain Protection in Schizophrenia, Mood and Cognitive Disorders. Brain Protection in Schizophrenia, Mood and Cognitive Disorders
45
66
.
Satoshi Yokoshima, Yuzo Abe, Naoto Watanabe, Yoichi Kita, Toshiyuki Kan, Takeshi Iwatsubo, Taisuke Tomita & Tohru Fukuyama. (2009) Development of photoaffinity probes for γ-secretase equipped with a nitrobenzenesulfonamide-type cleavable linker. Bioorganic & Medicinal Chemistry Letters 19:24, pages 6869-6871.
Crossref
Crossref
Rossen Donev, Martin Kolev, Bruno Millet & Johannes Thome. (2009) Neuronal death in Alzheimer’s disease and therapeutic opportunities. Journal of Cellular and Molecular Medicine 13:11-12, pages 4329-4348.
Crossref
Crossref
G. Simic, G. Stanic, M. Mladinov, N. Jovanov-Milosevic, I. Kostovic & P. R. Hof. (2009) Does Alzheimer's disease begin in the brainstem?. Neuropathology and Applied Neurobiology 35:6, pages 532-554.
Crossref
Crossref
Anthony F. Kreft, Robert Martone & Alexander Porte. (2009) Recent Advances in the Identification of γ-Secretase Inhibitors To Clinically Test the Aβ Oligomer Hypothesis of Alzheimer’s Disease. Journal of Medicinal Chemistry 52:20, pages 6169-6188.
Crossref
Crossref
Ikuo Hayashi, Sho Takatori, Yasuomi Urano, Hiroko Iwanari, Noriko Isoo, Satoko Osawa, Maiko A. Fukuda, Tatsuhiko Kodama, Takao Hamakubo, Tong Li, Philip C. Wong, Taisuke Tomita & Takeshi Iwatsubo. (2009) Single Chain Variable Fragment against Nicastrin Inhibits the γ-Secretase Activity. Journal of Biological Chemistry 284:41, pages 27838-27847.
Crossref
Crossref
Taisuke Tomita. (2009) Alzheimer's disease treatment by inhibition/modulation of the .GAMMA.-secretase activity. Rinsho Shinkeigaku 49:11, pages 845-847.
Crossref
Crossref